229 related articles for article (PubMed ID: 23838317)
1. The mechanism of DAB2IP in chemoresistance of prostate cancer cells.
Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT
Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
[TBL] [Abstract][Full Text] [Related]
3. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
4. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
Xie D; Gore C; Liu J; Pong RC; Mason R; Hao G; Long M; Kabbani W; Yu L; Zhang H; Chen H; Sun X; Boothman DA; Min W; Hsieh JT
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2485-90. PubMed ID: 20080667
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
6. DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation.
Xiong Z; Yang L; Li N; Fu J; Liu P; Sun P; Wei W; Xie X
Clin Transl Med; 2022 Dec; 12(12):e1133. PubMed ID: 36536485
[TBL] [Abstract][Full Text] [Related]
7. A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer.
Samadaian N; Salehipour P; Ayati M; Rakhshani N; Najafi A; Afsharpad M; Yazarlou F; Modarressi MH
Pathol Res Pract; 2018 Dec; 214(12):2018-2024. PubMed ID: 30301636
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
[TBL] [Abstract][Full Text] [Related]
9. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
Sowery RD; Hadaschik BA; So AI; Zoubeidi A; Fazli L; Hurtado-Coll A; Gleave ME
BJU Int; 2008 Aug; 102(3):389-97. PubMed ID: 18336596
[TBL] [Abstract][Full Text] [Related]
10. Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.
Zhang M; Osisami M; Dai J; Keller JM; Escara-Wilke J; Mizokami A; Keller ET
Mol Cancer Res; 2017 Apr; 15(4):457-466. PubMed ID: 28087740
[TBL] [Abstract][Full Text] [Related]
11. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
Zhang X; Wang Q; Zhang R; Kong Z
Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
[TBL] [Abstract][Full Text] [Related]
12. Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
Zhou J; Luo J; Wu K; Yun EJ; Kapur P; Pong RC; Du Y; Wang B; Authement C; Hernandez E; Yang J; Xiao G; Cha TL; Wu HC; Wu D; Margulis V; Lotan Y; Brugarolas J; He D; Hsieh JT
Oncogene; 2016 Sep; 35(35):4663-74. PubMed ID: 26876207
[TBL] [Abstract][Full Text] [Related]
13. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
[TBL] [Abstract][Full Text] [Related]
14. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells.
Chang R; He H; Mao G; Kong Z
Int J Radiat Biol; 2017 Apr; 93(4):386-393. PubMed ID: 27834104
[TBL] [Abstract][Full Text] [Related]
15. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
[TBL] [Abstract][Full Text] [Related]
16. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
Yang C; He H; Zhang T; Chen Y; Kong Z
Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
[TBL] [Abstract][Full Text] [Related]
17. Identification of docetaxel resistance genes in castration-resistant prostate cancer.
Marín-Aguilera M; Codony-Servat J; Kalko SG; Fernández PL; Bermudo R; Buxo E; Ribal MJ; Gascón P; Mellado B
Mol Cancer Ther; 2012 Feb; 11(2):329-39. PubMed ID: 22027694
[TBL] [Abstract][Full Text] [Related]
18. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.
Yun EJ; Baek ST; Xie D; Tseng SF; Dobin T; Hernandez E; Zhou J; Zhang L; Yang J; Sun H; Xiao G; He D; Kittler R; Hsieh JT
Oncogene; 2015 May; 34(21):2741-52. PubMed ID: 25043300
[TBL] [Abstract][Full Text] [Related]
19. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
[TBL] [Abstract][Full Text] [Related]
20. Clusterin mediates TRAIL resistance in prostate tumor cells.
Sallman DA; Chen X; Zhong B; Gilvary DL; Zhou J; Wei S; Djeu JY
Mol Cancer Ther; 2007 Nov; 6(11):2938-47. PubMed ID: 18025278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
